ID   HeLa-P4-R5 MAGI
AC   CVCL_1H21
SY   HeLa P4.R5; P4 MAGI CCR5+; P4.R5 MAGI; P4-R5 MAGI
DR   BEI_Resources; ARP-3580
DR   Wikidata; Q54937291
CC   Population: African American.
CC   Characteristics: Expression of CD4 is under the control of a mouse PGK promoter (from patent cell line).
CC   Characteristics: Transfected with a construct pMA175 containing the HIV-1 BRU LTR that allows expression of lacZ when Tat is present (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AR ! HeLa-P4
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 14
//